Characteristics of the Third COVID-19 Pandemic Wave with Special Focus on Socioeconomic Inequalities in Morbidity, Mortality and the Uptake of COVID-19 Vaccination in Hungary.
COVID-19
Roma
deprivation
excess mortality
morbidity
mortality
socioeconomic inequities
vaccination coverage
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
03 Mar 2022
03 Mar 2022
Historique:
received:
04
02
2022
revised:
28
02
2022
accepted:
01
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Governments are increasingly looking to vaccination to provide a path out of the COVID-19 pandemic. Hungary offers an example to investigate whether social inequalities compromise what a successful vaccine program can achieve. COVID-19 morbidity, mortality, and vaccination coverage were characterized by calculation of indirectly standardized ratios in the Hungarian population during the third pandemic wave at the level of municipalities, classified into deprivation quintiles. Then, their association with socioeconomic deprivation was assessed using ecological regression. Compared to the national average, people living in the most deprived municipalities had a 15-24% lower relative incidence of confirmed COVID-19 cases, but a 17-37% higher relative mortality and a 38% lower vaccination coverage. At an ecological level, COVID-19 mortality showed a strong positive association with deprivation and an inverse association with vaccination coverage (RR
Identifiants
pubmed: 35330387
pii: jpm12030388
doi: 10.3390/jpm12030388
pmc: PMC8954719
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Hungarian Academy of Sciences
ID : TK2016-78, project no. 135784
Organisme : National Research, Development and Innovation Fund of Hungary
ID : financed under the K_20 funding scheme
Références
BMJ Open. 2019 Jul 23;9(7):e024957
pubmed: 31340955
Lancet. 2021 Oct 16;398(10309):1407-1416
pubmed: 34619098
Vaccine. 2021 Jul 30;39(33):4716-4722
pubmed: 34119349
Clin Infect Dis. 2021 Sep 06;:
pubmed: 34487522
BMJ. 2020 Apr 27;369:m1557
pubmed: 32341002
MMWR Morb Mortal Wkly Rep. 2021 Jun 04;70(22):818-824
pubmed: 34081685
Environ Health Perspect. 2004 Jun;112(9):1016-25
pubmed: 15198922
Clin Microbiol Infect. 2021 Aug;27(8):1109-1117
pubmed: 34015535
Eur J Public Health. 2012 Oct;22(5):620-4
pubmed: 21965543
Int J Environ Res Public Health. 2020 Sep 19;17(18):
pubmed: 32961765
Front Pharmacol. 2016 Mar 24;7:66
pubmed: 27047381
Soc Sci Med. 2010 May;70(9):1342-9
pubmed: 20199838
Int J Environ Res Public Health. 2021 May 15;18(10):
pubmed: 34063476
Vaccine. 2021 Oct 8;39(42):6256-6261
pubmed: 34544601
Int J Environ Res Public Health. 2021 Feb 24;18(5):
pubmed: 33668088
Vaccine. 2022 Mar 18;40(13):2003-2010
pubmed: 35193793
Front Public Health. 2021 Sep 22;9:719665
pubmed: 34631647
Epidemiology. 2009 May;20(3):400-10
pubmed: 19318951
J R Soc Interface. 2021 Jul;18(180):20210009
pubmed: 34255985
Lancet. 2021 May 8;397(10286):1725-1735
pubmed: 33901423
Clin Microbiol Infect. 2022 Mar;28(3):398-404
pubmed: 34838783
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):431-436
pubmed: 33764963
Sci Rep. 2022 Jan 14;12(1):724
pubmed: 35031631
Environ Health Perspect. 2010 Sep;118(9):1306-12
pubmed: 20457552
Lancet Public Health. 2020 Jul;5(7):e375-e385
pubmed: 32502389
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34518205
Lancet Infect Dis. 2021 Jun;21(6):793-802
pubmed: 33743847
Vaccines (Basel). 2021 Sep 24;9(10):
pubmed: 34696179
BMJ. 2021 May 13;373:n1088
pubmed: 33985964
Lancet. 2021 Nov 13;398(10313):1825-1835
pubmed: 34717829
Vaccines (Basel). 2021 Dec 11;9(12):
pubmed: 34960213
Clin Microbiol Infect. 2022 Feb;28(2):202-221
pubmed: 34715347
Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S183-S190
pubmed: 28723704
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222
Stat Med. 1995 Apr 30;14(8):799-810
pubmed: 7644860